USTrend Signal
4
mentions (7d)
4
mentions (30d)
May 19, 2026
first seen
1
countries
Context & Analysis
This trend "Huntington's disease therapies under investigation in 2026 pipeline" was detected in the Health & Medicine category with a score of 98/100. This trend is experiencing explosive growth and attracting significant attention right now.
Related entities
Source excerpts
Consent to Cookies & Data processing We use cookies in accordance with our privacy policy linked below to process end device information and personal data. This serves the integration of content, external services and elements of third parties, statistical analysis/measurement, personalized advertising as well as the integration of social media. Depending on the function, data is thereby passed on to third parties, also in the USA, with the risk of secret access by US authorities and use for...
— openpr.com
What sources say
"DelveInsight's 2026 report outlines investigational therapies, clinical trial milestones, and development progress for Huntington's disease treatments."
"The American Society for Gene and Cell Therapy (ASGCT) CEO David Barrett, JD, noted there has been “a nice uptick” in Q1 in start-up funding compared to the..."
"In early May 2026, PTC Therapeutics reported first-quarter revenue of US$272.55 million versus US$1.18 billion a year earlier, swinging from net income of..."
"uniQure (QURE) stock dropped over 37% after a mixed earnings report. The FDA rejected their AMT-130 data package for Huntington's disease, recommending a..."